Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Angeforderte Firma
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Weiterlesen
Constant change. Lots of new people with new ways of working and expectations
Was ist das Beste an Ihrem Vergütungspaket?
Base salary since the stock is challenging.
Was müssen Ihre Mitarbeiter verbessern und wie könnten Sie besser zusammenarbeiten?
Open mind. Willingness to take ownership/
Was gefällt dir am besten am Führungsteam?
They seem to be working more collaboratively than before.
Was macht Sie bei der Arbeit am glücklichsten?
Providing value and being respected and appreciated for it.
Was ist am positivsten an Kultur und Umgang in Ihrem Unternehmen?
Seems to be evolving. Less blame and threatening than before.
Other Employee Reviews for Karyopharm Therapeutics
×